Viewing StudyNCT01078662



Ignite Creation Date: 2024-05-05 @ 10:17 PM
Last Modification Date: 2024-10-26 @ 10:17 AM
Study NCT ID: NCT01078662
Status: COMPLETED
Last Update Posted: 2024-06-20
First Post: 2010-03-01

Brief Title: Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Advanced Tumours
Ovarian
Breast
Prostate
Pancreatic
Keywords:
Name View
solid tumour refractory View
olaparib View
PARP inhibitors View
genetic BRCA1 mutation View
BRCA2 mutation View